Table 1.

Clinical status. Age at surgery and time to post-surgery non-diabetic state for pre-surgery diabetic subjects

Diabetics (DM)	223
By glycemic status	100
NDM post surgery	48
DMT2 post surgery	34
NDM post/treat DMT2	17	(see text)
By treatment only	123
NDM post surgery	112
DMT2 post surgery	11
Non-diabetics (NDM)	518
Not determined glycemic	5
Not determined glycemic/treat DMT2	1
Total	747
Fraction diabetics	0.3
Females	530
Males	217
Age at surgery	Glycemic DMT2			Treatment DMT2			NDM
	Females	Males	Females %	Females	Males	Females %	Females	Males	Females %
Number	54	46	54.0 %	70	53	56.9 %	402	116	77.6 %
Mean	49.58	50.31		48.55	48.5		41.97	41.02
Minimum	30.79	30.29		27.08	27.49		18.97	19.05
Maximum	64.65	65.53		61.95	61.83		65.37	59.18
Variance	71.66	50.14		77.68	69.14		91.38	83.39
Std	8.47	7.08		8.81	8.31		9.56	9.13
Females-Males. p-value*		0.642			0.975			0.33
Compare clinical status	Females	Males
NDM-Glycemic	<0.001	<0.001
NDM-Treatment	<0.001	<0.001
Glycemic-Treatment	0.512	0.248
Days to NDM after surgery	Glycemic DMT2			Treatment DMT2
	Females	Males		Females	Males
Number	33	32		59	41
Mean	202.55	201.94		146.64	178.61
Minimum	42	84		11	66
Maximum	708	696		451	751
Variance	21040	18975		8088	23356
Std	145	137		90	153
Females-Males. p-value		0.986			0.239

Glycemic DMT2 refers to patients classified as diabetics if HbA1c exceeds 48 mmol/mol regardless of any treatment. The Treatment DMT2 sub-population includes all subjects with HbA1c below 48 mmol/mol but received antidiabetic medical treatment (drugs or insulin)

*The p-values are given as nominal values. Only p-values <0.001 can be considered significant after Bonferoni correction for multiple testing